These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4746332)

  • 41. Temperature change and neuromuscular blockade by d-tubocurarine or pancuronium in man.
    Park WY; Macnamara TE
    Anesthesiology; 1979 Feb; 50(2):161-3. PubMed ID: 434491
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiovascular and neuromuscular effects of pancuronium bromide in the pony.
    Manley SV; Steffey EP; Howitt GA; Woliner M
    Am J Vet Res; 1983 Jul; 44(7):1349-53. PubMed ID: 6881672
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tubocurarine and psychopharmacologic agnets. 3. Thymoleptic antidepressants].
    Sansone M; Aulisio GA; Marino A
    Boll Soc Ital Biol Sper; 1967 Mar; 43(5):243-6. PubMed ID: 6060497
    [No Abstract]   [Full Text] [Related]  

  • 44. [Tubocurarine and psychopharmacologic agents. I. Minor tranquilizing agents].
    Sansone M; Aulisio GA; Marino A
    Boll Soc Ital Biol Sper; 1967 Mar; 43(5):236-9. PubMed ID: 6060495
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison of the potencies of a series of barbiturates at the neuromuscular junction and on the central nervous system.
    Lee-Son S; Waud BE; Waud DR
    J Pharmacol Exp Ther; 1975 Nov; 195(2):251-6. PubMed ID: 1185595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative neuromuscular blocking potency of pipecuronium and pancuronium.
    Youssef SA; Ramadan A; Ibrahim EI
    Dtsch Tierarztl Wochenschr; 1993 Oct; 100(10):396-8. PubMed ID: 8261906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of anemonotoxin on the neuromuscular transmission in skeletal and smooth muscle].
    Baĭdan LV; Kozlovskaia EP; Eliakov GB; Tishkin SM; Shuba MF
    Dokl Akad Nauk SSSR; 1981; 259(4):1000-2. PubMed ID: 6116588
    [No Abstract]   [Full Text] [Related]  

  • 48. Atracurium during halothane anesthesia in humans.
    Stirt JA; Murray AL; Katz RL; Schehl DL; Lee C
    Anesth Analg; 1983 Feb; 62(2):207-10. PubMed ID: 6687515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of bretylium on neuromuscular transmission.
    Welch GW; Waud BE
    Anesth Analg; 1982 May; 61(5):442-4. PubMed ID: 6278989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tubocrarine and psychopharmacologic agents. II. Major tranquilizing agents].
    Sansone M; Aulisio GA; Marino A
    Boll Soc Ital Biol Sper; 1967 Mar; 43(5):240-3. PubMed ID: 6060496
    [No Abstract]   [Full Text] [Related]  

  • 52. A new method to estimate apparent dissociation constants for desensitizing agonists without using antagonists.
    Morgenstern R
    Acta Biol Med Ger; 1974; 32(5):K23-9. PubMed ID: 4850244
    [No Abstract]   [Full Text] [Related]  

  • 53. Measurement of drug-receptor dissociation constants of muscarinic agonists on intestinal smooth muscle.
    Parker RB
    J Pharmacol Exp Ther; 1972 Jan; 180(1):62-70. PubMed ID: 5010418
    [No Abstract]   [Full Text] [Related]  

  • 54. A new kind of drug antagonism: evidence that agonists cause a molecular change in acetylcholine receptors.
    Rang HP; Ritter JM
    Mol Pharmacol; 1969 Jul; 5(4):394-411. PubMed ID: 5805474
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tubocurarine and psychopharmacologic agents. IV. Thymeretic antidepressants].
    Sansone M; Aulisio GA; Marino A
    Boll Soc Ital Biol Sper; 1967 Mar; 43(5):246-9. PubMed ID: 6060498
    [No Abstract]   [Full Text] [Related]  

  • 56. Nature of postjunctional receptors.
    Hu JH
    Am J Physiol; 1972 Oct; 223(4):882-7. PubMed ID: 4538564
    [No Abstract]   [Full Text] [Related]  

  • 57. The interaction of ketamine with d-tubocurarine, pancuronium, and succinylcholine in man.
    Johnston RR; Miller RD; Way WL
    Anesth Analg; 1974; 53(4):496-501. PubMed ID: 4858244
    [No Abstract]   [Full Text] [Related]  

  • 58. Competitive block and ion channel block as mechanisms of antagonist action on the skeletal muscle end-plate.
    Colquhoun D
    Adv Biochem Psychopharmacol; 1980; 21():67-80. PubMed ID: 6246760
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chemical structure and spasmolytic activity of organo-boric compounds].
    Caujolle F; Pham-Huu-Chanh
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):467-74. PubMed ID: 4386707
    [No Abstract]   [Full Text] [Related]  

  • 60. Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man.
    Stanski DR; Ham J; Miller RD; Sheiner LB
    Anesthesiology; 1980 Jun; 52(6):483-7. PubMed ID: 7377594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.